Citizen Portal
Sign In

Get Full Government Meeting Transcripts, Videos, & Alerts Forever!

Get email alerts on the Public Health Pans topic

No spam. Unsubscribe anytime.

House directs study of PANS/PANDAS after emotional testimony from parents

House of Representatives · June 30, 2026
AI-Generated Content: All content on this page was generated by AI to highlight key points from the meeting. For complete details and context, we recommend watching the full video. so we can fix them.

Summary

The Pennsylvania House adopted a resolution directing a study of pediatric acute-onset neuropsychiatric syndrome (PANS) and PANDAS after lawmakers heard personal testimony about misdiagnosis, limited provider capacity and uneven insurance coverage.

The Pennsylvania House on June 30 adopted House Resolution 528 directing the Joint State Government Commission to study pediatric acute-onset neuropsychiatric syndrome (PANS) and pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections (PANDAS).

"This is not a hypothetical situation," Representative Cooper said on the House floor, describing children who suddenly develop severe anxiety, tics and other disabling behaviors and estimating the condition affects "as many as 1 in 200 families" and "more than 13,000 families" in Pennsylvania. Cooper said providers with expertise are limited and insurance coverage is inconsistent, and called the resolution "a critical step forward."

Representative Walsh offered a first-person account in support, describing a child in his family who developed severe behavioral symptoms after an infection and saying therapies and hospitalizations failed to help. "No family should have to navigate this journey without answers," Walsh said, urging colleagues to back the study.

The resolution directs a comprehensive review of awareness, insurance practices, provider capacity, misdiagnosis impacts and state policy gaps, with recommendations to improve diagnosis, treatment and supports. Lawmakers noted that guidance from the Pennsylvania Rare Disease Advisory Council has not yet been issued.

The House recorded the vote on the resolution as ayes 201 and nays 1; the resolution was adopted. Next steps for the commission and any timetable for the study were not detailed on the floor.

The measure was introduced during the afternoon session and followed by other floor business, including several ceremonial resolutions and a series of bills called for final passage.